MYASTHENIA GRAVIS, OCULAR
Clinical trials for MYASTHENIA GRAVIS, OCULAR explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, OCULAR trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, OCULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to ease droopy eyelids and double vision
Disease control Recruiting nowThis Phase 3 trial tests whether telitacicept can improve eye muscle symptoms in people with ocular myasthenia gravis, a condition causing droopy eyelids and double vision. About 120 participants aged 12 to 80 will receive either the drug or a placebo for 24 weeks. The study meas…
Matched conditions: MYASTHENIA GRAVIS, OCULAR
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can tracking daily life unlock myasthenia gravis mysteries?
Knowledge-focused Recruiting nowThis registry study follows adults with myasthenia gravis (MG) over time to understand how symptoms, daily functioning, and quality of life change. Participants complete surveys about their symptoms, treatments, and challenges, and may share medical records. The goal is to gather…
Matched conditions: MYASTHENIA GRAVIS, OCULAR
Sponsor: Autoimmune Neurology Alliance • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC